Related Experiment Video
Updated: Sep 25, 2026

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
Published on: June 23, 2022
Cardiac complications after elective major vascular surgery
M D Kertai1, J Klein, H van Urk
1Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Insights
Major vascular surgery patients face significant cardiac risks. This review details cardiovascular disease management, recommending beta-blockers for all and reserving revascularization for independent needs.
Area of Science:
- Cardiology
- Vascular Surgery
- Anesthesiology
Background:
- Cardiac complications are a leading cause of death and disability in patients undergoing major vascular surgery.
- Understanding cardiovascular disease (CVD) is crucial for managing perioperative risks.
Purpose of the Study:
- To review the pathophysiology of perioperative cardiac complications.
- To outline risk assessment and reduction strategies for CVD in vascular surgery patients.
Main Methods:
- Literature review focusing on perioperative cardiac events in vascular surgery.
- Analysis of risk factors and management guidelines for cardiovascular disease.
Main Results:
- Patients without cardiac risk factors are low-risk; no routine coronary artery disease evaluation is needed.
- Beta-adrenergic blockers may decrease perioperative cardiac events.
- Patients with cardiac risk factors are intermediate to high-risk.
Conclusions:
- Beta-adrenergic blockers should be administered to all patients undergoing major vascular surgery.
- Coronary revascularization should be reserved for patients with independent indications, not solely for vascular surgery needs.
Abstract:
Cardiac complications are the major cause of perioperative and late mortality and morbidity in patients undergoing elective major vascular surgery. This review focuses on the pathophysiology of perioperative complications, risk assessment and risk reduction strategies, all related to cardiovascular disease. Patients without cardiac risk factors are considered to be at low risk and no additional evaluation for coronary artery disease is recommended; beta-adrenergic blockers may reduce perioperative cardiac events; patients with one or more risk factors represent an intermediate to high-risk population. beta-Adrenergic blockers should be prescribed to all patients and coronary revascularization should be reserved for patients who have a clearly defined need for revascularization independent of the need for vascular surgery.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiac Catheterization II: Right Heart Catheterization
Aneurysm IV: Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management